Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

What's Left For Threshold? Not Much
Seeking Alpha
Wednesday, October 24, 2012 - 12:00pm
tags:
Threshold Pharmaceuticals, TH-302
Questcor Earnings: Knocking It Out of the Park
Motley Fool
Wednesday, October 24, 2012 - 11:56am
tags:
earnings, Questcor
Regeneron posts strong 3rd-quarter results on new approvals; raises Eylea sales estimate
Yahoo/AP
Wednesday, October 24, 2012 - 11:55am
tags:
earnings, Regeneron
Spectrum Pharma: Guessing Q3 Fusilev Sales
TheStreet.com
Wednesday, October 24, 2012 - 11:54am
tags:
Spectrum Pharmaceuticals, earnings
Alexion Pharma 3rd-quarter net income rises on broader Soliris approval and settlement
Yahoo/AP
Wednesday, October 24, 2012 - 11:53am
tags:
Alexion, earnings
Q3 biotech venture investing makes a boisterous leap
Fierce Biotech
Wednesday, October 24, 2012 - 11:53am
tags:
venture capital, biotech
Lupin eyes 15 new drug launches in US by March 2013
Economic Times, India
Wednesday, October 24, 2012 - 11:46am
tags:
India, Lupin
Teva reports Phase III study results of Quartette contraceptive
The Fly on the Wall
Wednesday, October 24, 2012 - 11:44am
tags:
Teva, Quartette, birth control pill, contraceptives
United Therapeutics Falls as FDA Rejects Oral Remodulin
Bloomberg
Wednesday, October 24, 2012 - 11:43am
tags:
FDA, Remodulin, United Therapeutics, PAH
Pfizer lung cancer drug gets conditional EU approval
Reuters
Wednesday, October 24, 2012 - 11:42am
tags:
Pfizer, Europe, non-small cell lung cancer, Xalkori
Italy bans Novartis flu vaccines pending tests
Reuters
Wednesday, October 24, 2012 - 11:41am
tags:
Italy, Novartis, Flu, vaccines
Bristol-Myers results lag as Plavix sales evaporate
Reuters
Wednesday, October 24, 2012 - 11:00am
tags:
Bristol-Myers Squibb, earnings
AstraZeneca may launch cash bid for Amarin, Daily Mail reports
Yahoo/Fly on the Wall
Wednesday, October 24, 2012 - 10:59am
tags:
AstraZeneca, M&A, Amarin
Aegerion's Lomitapide - FDA Approval, Strong Launch, Stock Price Increase Anticipated
Seeking Alpha
Wednesday, October 24, 2012 - 10:58am
tags:
lomitapide, FDA, Aegerion, Homozygous Familial Hypercholesterolemia
Eli Lilly's 3rd quarter profit climbs 7 pct, revenue slides and drugmaker backs 2012 forecast
Yahoo/AP
Wednesday, October 24, 2012 - 10:57am
tags:
Eli Lilly, earnings
Amgen 3rd quarter profit higher, raises 2012 forecast
Reuters
Tuesday, October 23, 2012 - 4:50pm
tags:
Amgen, earnings
Gilead net drops on higher expenses
Marketwatch
Tuesday, October 23, 2012 - 4:31pm
tags:
Gilead, earnings
Cleveland Biolabs: Gunning For $50 Million In Government Funding
Seeking Alpha
Tuesday, October 23, 2012 - 4:30pm
tags:
Cleveland BioLabs, government funding, entolimod, anti-radiation
Ironwood long-term outlook positive, says Ladenburg
Yahoo/Fly on the Wall
Tuesday, October 23, 2012 - 4:29pm
tags:
Ironwood Pharmaceuticals, linaclotide, AstraZeneca, China
FDA Label Expansion for Abraxane
Yahoo/Zacks
Tuesday, October 23, 2012 - 4:21pm
tags:
FDA, Abraxane, non-small cell lung cancer, Celgene

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.